Tying these polygenic score cost effectiveness studies in here as most have been published since the ICDA PRS Task Force paper. As one would expect from a one-time sub-£100 assay that can be applied to dozens of clinical pathways, PGS cost effectiveness i
RT @minouye271: Studies assessing cost-effectiveness of polygenic scores in screening Breast cancer: https://t.co/M0Ospc4Xkh https://t.co/q…
RT @minouye271: Studies assessing cost-effectiveness of polygenic scores in screening Breast cancer: https://t.co/M0Ospc4Xkh https://t.co/q…
Glad to see more research answering this question!